G deduction and interest under TDS/TCS provisions. The Tribunal found that the Assessing Officer had examined both issues and no prejudice was ...
StockStory.org on MSN
SNX Q4 deep dive: Growth in cloud and AI infrastructure offsets margin stability concerns
IT distribution giant TD SYNNEX (NYSE:SNX) reported in Q4 CY2025, with sales up 9.7% year on year to $17.38 billion. The ...
ET Now on MSN
Aurobindo Pharma’s arm CuraTeQ Biologics receives Health Canada NOC for cancer drug biosimilar Dyrupeg
Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received Health Canada’s compliance notice for its biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback